Abstract
Adrenocorticotropic hormone (ACTH)-secreting lung carcinoids represent the principal cause of ectopic Cushing syndrome, but the prevalence of ACTH expression and the association between ACTH production and Cushing syndrome in lung carcinoids have scarcely been investigated. In addition, available information on the prognostic meaning of ACTH production is controversial. The aims of this multicentric retrospective study, also including a review of the literature, were to describe the clinico-pathologic features of ACTH-producing lung carcinoids, to assess recurrence and specific survival rates, and to evaluate potential prognostic factors. To identify ACTH production in 254 unselected and radically resected lung carcinoids, we used a double approach including RT-PCR (mRNA encoding for pro-opiomelanocortin) and immunohistochemistry (antibodies against ACTH and β-endorphin). Sixty-three (24.8%) tumors produced ACTH and 11 of them (17.4%), representing 4.3% of the whole series, were associated with Cushing syndrome. The median follow-up time was 71 months. The 10-year overall and specific survival rates were 88.5% and 98.2%, respectively, with difference neither between functioning and nonfunctioning tumors nor between ACTH-positive and ACTH-negative carcinoids. At univariate analysis, histological type (typical or atypical) and Ki67 index significantly correlated with tumor recurrence. The literature review identified 172 previously reported patients with functioning ACTH-secreting lung carcinoids, and the meta-analysis of survival showed that 92% of them were alive after a mean follow-up time of 50 months. Our results demonstrate that ACTH-producing lung carcinoids are not rare, are not always associated with Cushing syndrome, and do not represent an aggressive variant of lung carcinoid.
Similar content being viewed by others
References
Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (2015) WHO classification of tumours of the lung, pleura, thymus and heart, 4th edn. IARC Press, Lyon
Daddi N, Schiavon M, Filosso PL, Cardillo G, Ambrogi MC, de Palma A, Luzzi L, Bandiera A, Casali C, Ruffato A, de Angelis V, Andriolo LG, Guerrera F, Carleo F, Davini F, Urbani M, Mattioli S, Morandi U, Zannini P, Gotti G, Loizzi M, Puma F, Mussi A, Ricci A, Oliaro A, Rea F, on behalf of the Multi-Institutional Italian Pathology Group, Capozzi R, Tassi V, Pagliarulo V, Ghisalberti M, Calabrese F, Sapino A, Delsedime L, Graziano P, Ali G, Fontanini G, Sidoni A, Ascani S, Trabucco X, Sina D, Arrigoni G, Rossi G, Agostinelli C (2014) Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids. Eur J Cardiothorac Surg 45:677–686
Filosso PL, Oliaro A, Ruffini E, Bora G, Lyberis P, Asioli S, Delsedime L, Sandri A, Guerrera F (2013) Outcome and prognostic factors in bronchial carcinoids: a single-center experience. J Thorac Oncol 8:1282–1288
Cardillo G, Sera F, Di Martino M, Graziano P, Giunti R, Carbone L, Facciolo F, Martelli M (2004) Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg 77:1781–1785
Maurizi G, Ibrahim M, Andreetti C, D’Andrilli A, Ciccone AM, Pomes LM, Menna C, Pellegrini M, Venuta F, Rendina EA (2014) Long-term results after resection of bronchial carcinoid tumour: evaluation of survival and prognostic factors. Interact Cardiovasc Thorac Surg 19:239–244
Rindi G, Klersy C, Inzani F et al (2013) Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer 21:1–16
Pelosi G, Rindi G, Travis WD, Papotti M (2014) Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice. J Thorac Oncol 9:273–284
Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, el-Naggar AK, Fernandez-Cuesta L, Klöppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31:1770–1786
Shrager JB, Wright CD, Wain JC, Torchiana DF, Grillo HC, Mathisen DJ (1997) Bronchopulmonary carcinoid tumors associated with Cushing’s syndrome: a more aggressive variant of typical carcinoid. J Thorac Cardiovasc Surg 114:367–375
Boddaert G, Grand B, Le Pimpec-Barthes F, Cazes A, Bertagna X, Riquet M (2012) Bronchial carcinoid tumors causing Cushing’s syndrome: more aggressive behavior and the need for early diagnosis. Ann Thorac Surg 94:1823–1829
Lococo F, Margaritora S, Cardillo G, Filosso P, Novellis P, Rapicetta C, Carleo F, Bora G, Cesario A, Stefani A, Rossi G, Paci M (2016) Bronchopulmonary carcinoids causing Cushing syndrome: results from a multicentric study suggesting a more aggressive behavior. Thorac Cardiovasc Surg 64:172–181
Scanagatta P, Montresor E, Pergher S, Mainente M, Bonadiman C, Benato C, Feil B, Destefanis ML, Pea M, Spinoso A, Scilanga L, Francia G (2004) Cushing’s syndrome induced by bronchopulmonary carcinoid tumours: a review of 98 cases and our experience of two cases. Chir Ital 56:63–70
Deb SJ, Nichols FC, Allen MS, Deschamps C, Cassivi SD, Pairolero PC (2005) Pulmonary carcinoid tumors with Cushing’s syndrome: an aggressive variant or not? Ann Thorac Surg 79:1132–1136
Vesterinen T, Mononen S, Salmenkivi K, Mustonen H, Ilonen I, Knuuttila A, Haglund C, Arola J (2018) Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor. Acta Oncol 5:1109–1116
Brieley JD, Gospodarowicz MK, Wittekind C (2017) UICC TNM classification of malignant tumours, 8th edn. Wiley Blackwell, London
Ceppi P, Volante M, Saviozzi S, Rapa I, Novello S, Cambieri A, Lo Iacono M, Cappia S, Papotti M, Scagliotti GV (2006) Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase. Cancer 107:1589–1596
Righi A, Morandi L, Leonardi E, Farnedi A, Marucci G, Sisto A, Frank G, Faustini-Fustini M, Zoli M, Mazzatenta D, Agati R, Foschini MP (2013) Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior. Hum Pathol 44:2400–2409
La Rosa S, Vigetti D, Placidi C, Finzi G, Uccella S, Clerici M, Bartolini B, Carnevali I, Losa M, Capella C (2010) Localization of carboxyl ester lipase in human pituitary gland and pituitary adenomas. J Histochem Cytochem 58:881–889
La Rosa S, Uccella S, Dainese L, Marchet S, Placidi C, Vigetti D, Capella C (2008) Characterization of c-kit (CD117) expression in human normal pituitary cells and pituitary adenomas. Endocr Pathol 19:104–111
Cohen RB, Toll GD, Castleman B (1960) Bronchial adenomas in Cushing’s syndrome: their relation to thymomas and oat cell carcinomas associated with hyperadrenocorticism. Cancer 13:812–817
Lloyd RV, Osamura RY, Klöppel G, Rosai J (2017) WHO classification of tumours of endocrine organs, 4th edn. IARC Press, Lyon
Maragliano R, Vanoli A, Albarello L, Milione M, Basturk O, Klimstra DS, Wachtel A, Uccella S, Vicari E, Milesi M, Davì MV, Scarpa A, Sessa F, Capella C, La Rosa S (2015) ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature. Am J Surg Pathol 39:374–382
Reincke M (2000) Subclinical Cushing’s syndrome. Endocrinol Metab Clin N Am 29:43–56
Uccella S, La Rosa S, Volante M, Papotti M (2018) Immunohistochemical biomarkers of gastrointestinal, pancreatic, pulmonary, and thymic neuroendocrine neoplasms. Endocr Pathol 29:150–168
Funding
This study was partly supported by a grant from the Italian Association for Cancer Research (AIRC) (IG 19238 to MV).
Author information
Authors and Affiliations
Contributions
All authors have made a substantial contribution to conception and execution of the study including acquisition of data, processing material, analysis, and interpretation of data, as well as writing and reviewing the manuscript. All authors have approved the manuscript.
Corresponding author
Ethics declarations
This study was performed according to the clinical standards of the 1975 and 1983 Declaration of Helsinki and was approved by the Ethical Committee of the ASST dei Sette Laghi.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 165 kb)
Rights and permissions
About this article
Cite this article
La Rosa, S., Volante, M., Uccella, S. et al. ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature. Virchows Arch 475, 587–597 (2019). https://doi.org/10.1007/s00428-019-02612-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-019-02612-x